Bernstein Harold bought MAZE
February 2, 2026 · Form 4 insider transaction
Bernstein Harold bought 15,000 shares of Maze Therapeutics, Inc. at $10.42 per share, a transaction worth $156.3K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
15,000
Price
$10.42
Total value
$156.3K
InsiderBernstein Harold
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 2, 2026
Filing dateFebruary 4, 2026
Shares owned after15,000
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.